Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation studyAdrian Bloor, Amit Patel, James E. Griffin et al.|Nature Medicine|2020Cited by 289
Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patientsAlexandros Spyridonidis, Mohamad Mohty, Nöel Milpied et al.|Bone Marrow Transplantation|2020Cited by 202
Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with <i>FLT3</i>-internal tandem duplication: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationAli Bazarbachi, Mohamad Mohty, Gesine Bug et al.|Haematologica|2020Cited by 137
Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow TransplantationÉolia Brissot, Mohamad Mohty, Myriam Labopin et al.|Bone Marrow Transplantation|2020Cited by 74
Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMTZachariah DeFilipp, Bronwen E. Shaw, Rafael F. Duarte et al.|Biology of Blood and Marrow Transplantation|2016Cited by 64